The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock

Summary

The first objective of this study was to characterize the pharmacokinetics and pharmacodynamics of daptomycin with a daily dose of 12mg/kg in septic shock patient; the second objective is to identify the optimal dosing scheme for daptomycin among patients with septic shock and to enhance therapeutic outcomes.

Timeline

Start

2015-01

Primary completion

2015-12

Completion

2016-06

Drugs

Indications